Jefferies Group LLC Allakos Inc. Put Options Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $5,130 - $67,134	-600 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $4.55 Million - $6.56 Million	-59,400 Reduced 99.0%	600 $64,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $5.07 Million - $6.78 Million	59,400 Added 9900.0%	60,000 $51,000
Q4 2020 Sep 21, 2023	BUY	$79.58 - $152.45 $47,748 - $91,470	600 New	600 $84,000
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $2.24 Million - $4.3 Million	-28,200 Reduced 97.92%	600 $84,000
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $2.72 Million - $5.72 Million	-61,200 Reduced 68.0%	28,800 $1.28 Million
Q4 2019 Feb 13, 2020	BUY	$66.49 - $137.73 $5.98 Million - $12.4 Million	90,000 New	90,000 $8.58 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $79.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.